The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The TIME trial: Phase II randomized controlled trial of time-of-day–specified immunotherapy for advanced melanoma.
 
Zachary Buchwald
Travel, Accommodations, Expenses - Alpha TAU Medical
 
David Qian
No Relationships to Disclose
 
Jeffrey Switchenko
No Relationships to Disclose
 
Melinda Yushak
Research Funding - Bristol Myers Squibb (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Regeneron (Inst); Replimune (Inst); Tesaro (Inst)
 
David Lawson
No Relationships to Disclose
 
Michael Lowe
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Merck; Regeneron; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Merck (Inst); Regeneron (Inst); Skyline Diagnostics (Inst); Vaccinex (Inst)